These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

329 related items for PubMed ID: 24694915

  • 1. [Analysis of clinical efficacy of intensity-modulated radiation therapy and the prognosis factors in advanced cervical cancer].
    Gao K, Ding L, Li L.
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jan; 49(1):30-5. PubMed ID: 24694915
    [Abstract] [Full Text] [Related]

  • 2. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study.
    Gandhi AK, Sharma DN, Rath GK, Julka PK, Subramani V, Sharma S, Manigandan D, Laviraj MA, Kumar S, Thulkar S.
    Int J Radiat Oncol Biol Phys; 2013 Nov 01; 87(3):542-8. PubMed ID: 24074927
    [Abstract] [Full Text] [Related]

  • 3. [Application value of reduced field intensity modulated radiation therapy for advanced cervical cancer].
    DU XL, Sheng XG, Wang C, Yu H, Song QQ, Pan CX.
    Zhonghua Zhong Liu Za Zhi; 2013 Dec 01; 35(12):925-31. PubMed ID: 24506963
    [Abstract] [Full Text] [Related]

  • 4. Intensity-modulated radiation therapy for advanced cervical cancer: a comparison of dosimetric and clinical outcomes with conventional radiotherapy.
    Du XL, Tao J, Sheng XG, Lu CH, Yu H, Wang C, Song QQ, Li QS, Pan CX.
    Gynecol Oncol; 2012 Apr 01; 125(1):151-7. PubMed ID: 22198339
    [Abstract] [Full Text] [Related]

  • 5. [Clinical study of intensity modulated radiotherapy and three-dimensional conformal radiotherapy with three-dimensional brachytherapy and concurrent chemotherapy for patients with advanced cervical cancer].
    Du XX, Yang H, Zhang HJ, Li LA, Fan WS, Meng YG.
    Zhonghua Fu Chan Ke Za Zhi; 2017 Oct 25; 52(10):679-686. PubMed ID: 29060966
    [Abstract] [Full Text] [Related]

  • 6. The Treatment of Pelvic Locoregional Recurrence of Cervical Cancer After Radical Surgery With Intensity-Modulated Radiation Therapy Compared With Conventional Radiotherapy: A Retrospective Study.
    Yin YJ, Li HQ, Sheng XG, Du XL, Wang C, Lu CH, Pan CX.
    Int J Gynecol Cancer; 2015 Jul 25; 25(6):1058-65. PubMed ID: 25647254
    [Abstract] [Full Text] [Related]

  • 7. [Comparison of survival and chronic gastrointestinal toxicities in patients with locally advanced cervical cancer, treated by conventional or intensity-modulated radiation technique].
    Gamelon-Bénichou C, Oldrini S, Charra-Brunaud C, Vogin G, Salleron J, Peiffert D.
    Cancer Radiother; 2017 May 25; 21(3):171-179. PubMed ID: 28457817
    [Abstract] [Full Text] [Related]

  • 8. [Preliminary study of intensity-modulated radiation therapy for recurrent cervical cancer].
    Zhou Q, Tang Y, Shu XL, Liu L.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov 25; 42(11):730-2. PubMed ID: 18307896
    [Abstract] [Full Text] [Related]

  • 9. Toxicity and cost-effectiveness analysis of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for postoperative treatment of gynecologic cancers.
    Chen LA, Kim J, Boucher K, Terakedis B, Williams B, Nickman NA, Gaffney DK.
    Gynecol Oncol; 2015 Mar 25; 136(3):521-8. PubMed ID: 25562668
    [Abstract] [Full Text] [Related]

  • 10. [Effects of pre-chemotherapy hemoglobin and platelet levels in patients with stage Ib2-IIb cervical cancer treated with neoadjuvant chemotherapy followed by radical hysterectomy].
    Wang D, Wu M, Ren T, Wan XR, Feng FZ, Huang HF, Yang JX, Shen K, Xiang Y.
    Zhonghua Fu Chan Ke Za Zhi; 2012 Aug 25; 47(8):577-81. PubMed ID: 23141176
    [Abstract] [Full Text] [Related]

  • 11. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
    Lohia S, Rajapurkar M, Nguyen SA, Sharma AK, Gillespie MB, Day TA.
    JAMA Otolaryngol Head Neck Surg; 2014 Apr 25; 140(4):331-7. PubMed ID: 24557509
    [Abstract] [Full Text] [Related]

  • 12. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
    Marnitz S, Martus P, Köhler C, Stromberger C, Asse E, Mallmann P, Schmidberger H, Affonso Júnior RJ, Nunes JS, Sehouli J, Budach V.
    Int J Radiat Oncol Biol Phys; 2016 Feb 01; 94(2):243-53. PubMed ID: 26853333
    [Abstract] [Full Text] [Related]

  • 13. Comparison of clinical outcomes and toxicity in endometrial cancer patients treated with adjuvant intensity-modulated radiation therapy or conventional radiotherapy.
    Chen CC, Wang L, Lu CH, Lin JC, Jan JS.
    J Formos Med Assoc; 2014 Dec 01; 113(12):949-55. PubMed ID: 24144528
    [Abstract] [Full Text] [Related]

  • 14. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
    Deville C, Both S, Hwang WT, Tochner Z, Vapiwala N.
    Int J Radiat Oncol Biol Phys; 2010 Nov 01; 78(3):763-72. PubMed ID: 20171807
    [Abstract] [Full Text] [Related]

  • 15. Normal tissue complication probability analysis of acute gastrointestinal toxicity in cervical cancer patients undergoing intensity modulated radiation therapy and concurrent cisplatin.
    Simpson DR, Song WY, Moiseenko V, Rose BS, Yashar CM, Mundt AJ, Mell LK.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):e81-6. PubMed ID: 22516388
    [Abstract] [Full Text] [Related]

  • 16. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
    Deville C, Vapiwala N, Hwang WT, Lin H, Ad VB, Tochner Z, Both S.
    Int J Radiat Oncol Biol Phys; 2012 Mar 15; 82(4):1389-96. PubMed ID: 21664069
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
    Kim YB, Kim GE, Cho NH, Pyo HR, Shim SJ, Chang SK, Park HC, Suh CO, Park TK, Kim BS.
    Cancer; 2002 Aug 01; 95(3):531-9. PubMed ID: 12209745
    [Abstract] [Full Text] [Related]

  • 18. Adjuvant concurrent chemoradiotherapy with intensity-modulated pelvic radiotherapy after surgery for high-risk, early stage cervical cancer patients.
    Chen MF, Tseng CJ, Tseng CC, Yu CY, Wu CT, Chen WC.
    Cancer J; 2008 Aug 01; 14(3):200-6. PubMed ID: 18536561
    [Abstract] [Full Text] [Related]

  • 19. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R, Zhang H, Zou L, Qu Y.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb 01; 50(2):125-30. PubMed ID: 25877610
    [Abstract] [Full Text] [Related]

  • 20. National Cancer Data Base analysis of radiation therapy consolidation modality for cervical cancer: the impact of new technological advancements.
    Gill BS, Lin JF, Krivak TC, Sukumvanich P, Laskey RA, Ross MS, Lesnock JL, Beriwal S.
    Int J Radiat Oncol Biol Phys; 2014 Dec 01; 90(5):1083-90. PubMed ID: 25216857
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.